Crossmark

Advancements in genetic research and RNA therapy strategies for amyotrophic lateral sclerosis (ALS): current progress and future prospects

Published Online: 2025-02-26

Published Print: 2025-03

Authors

Ruffo, Paola https://orcid.org/0000-0001-6246-5901
Traynor, Bryan J.

Conforti, Francesca Luisa
Funding

Funding for this research was provided by:

National Institute on Aging

National Institute on Aging
License Information

Text and Data Mining valid from 2025-02-26

Version of Record valid from 2025-02-26
More Information

Article History

Received: 12 November 2024

Revised: 12 February 2025

Accepted: 14 February 2025

First Online: 26 February 2025

Declarations

:

: BJT holds patents on the clinical testing and therapeutic intervention for the hexanucleotide repeat expansion of C9orf72, and has a patent pending (U.S. Patent Application No. 63/717,807) on the diagnostic testing for ALS based on the proteomic panel. The authors declare no other competing interests.

Document is current